Short-Term Outcomes of the Grammont Reverse Shoulder Arthroplasty: Comparison between First and Second Generation Delta Prosthesis by Alberio, Riccardo Luigi et al.
Short-Term Outcomes of the Grammont Reverse
Shoulder Arthroplasty: Comparison between
First and Second Generation Delta Prosthesis
Riccardo Luigi Alberio1 Marco Landrino1 Paolo Fornara1 Federico Alberto Grassi1
1Department of Orthopaedics and Traumatology, University of East
Piedmont, Hospital “Maggiore della Carità,” Novara, Italy
Joints 2019;7:141–147.
Address for correspondence Riccardo Luigi Alberio, MD, Department
of Orthopaedics and Traumatology, University of East Piedmont,










Abstract Purpose This article compares short-term outcomes of two series of patients, who
underwent reverse total shoulder arthroplasty (RTSA) with two different implants,
both based on Grammont’s principles: the Delta III (D-3) and the Delta Xtend (D-XT)
prostheses.
Methods The D-3 group included a consecutive series of 26 patients (mean age 75
years), that were treated between 2000 and 2006; the D-XT group included a
consecutive series of 31 patients (mean age 72.5 years), for a total of 33 implants
performed between 2011 and 2015. In both groups the most common diagnoses were
cuff tear arthropathy (18 and 22 shoulders, respectively) and malunion of proximal
humerus fractures (3 and 5). All procedures were performed by the same surgeon.
Constant–Murley score (CMS) was used to assess clinical and functional outcomes.
Radiographic evaluation included the true anteroposterior and axillary views.
Results Twenty-three patients of the D-3 group and 22 patients (24 shoulders) of the
D-XT group were evaluated at a mean follow-up of 42 months (range 26–84) and
44 months (range 26–66), respectively. Four complications occurred in the D-3 group
(1 partial deltoid detachment, 1 dislocation, and 2 glenoid component loosening),
while one early postoperative infection occurred in the D-XT group. Increases in
elevation and CMS between preoperative and postoperative period were observed in
both groups; only the D-XT group showed a slight improvement in rotations. The
incidence of scapular notching was significantly different between the two groups:
100% for D-3 and 22.2% for D-XT in patients with a minimum follow-up of 5 years.
Conclusion Prosthetic design evolution and greater acquaintance with this surgery
have undoubtedly led to an improvement in short-term outcomes with second
generation implants of RTSA. Future studies will have to ascertain whether newer
implants, relying on biomechanical solutions alternative to Grammont’s original
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Grammont reverse total shoulder arthroplasty (RTSA) was a
revolutionary solution for the surgical management of cuff
tear arthropathy1 and other difficult shoulder conditions,
such as fracture sequelae of proximal humerus and failed
prostheses.2 RTSA has also shown to be effective for the
treatment of proximal humeral fractures, particularly in
elderly patients or in cuff-deficient shoulders.3–7 During
the last decade, the worldwide use of RTSA as well as the
scientific literature related to this topic have steadily in-
creased and several prosthetic models have been introduced
on the market.
The reverse prosthesis aims to provide a fixed fulcrum for
deltoid action in case of cuff failure. The original Delta design,
developed by Paul Grammont in the eighties, was character-
ized by the medialization of the center of rotation and the
155-degree inclination of the humeral component. These
features allowed to decrease shear and bending stresses at
the scapular bone-prosthesis interface, and achieve joint
stability by deltoid coaptation.
However, the earlier clinical experiences highlighted
some biomechanical drawbacks of RTSA as well as a high
incidence of complications, such as infections and instabili-
ty.8–10 Scapular notching was the main reason for concern,
because it could be responsible for progressive bone loss of
the scapular neck and subsequent loosening of the glenoid
component, a condition with limited treatment options.
The second generation Delta prosthesis introduced some
innovations to overcome this problem, but the implant still
relied on Grammont medialization concept. The new design
included a smaller baseplate and eccentric glenospheres to
facilitate lowering of the glenoid component.11–13 Less con-
gruent humeral inserts were introduced for preventing
polyethylene wear while improving range of motion
(ROM).14 Curved back baseplate and thinner humeral epiph-
ysis aimed to preserve glenoid and humeral bone stock,
respectively.
The purpose of this study is to present a retrospective
evaluation of a single-surgeon experience with RTSA, by
analyzing and comparing the short-term clinical and radio-
graphic results achieved in two series of patients treated
with the Grammont RTSA in two different time periods. The
earliest series included patients treated with the first gener-
ation Delta prosthesis between 2000 and 2006, while
the second series included patients treated with
the second generation Delta prosthesis between 2011 and
2015.
We hypothesize that technological and surgical advances
in RTSA resulted in better clinical outcomes and lower
complication rates.
Methods
This retrospective study was performed on two group of
patients, that underwent RTSA in two different time periods.
All patients were affected by nontraumatic problems of the
shoulder and had a minimum follow-up of 2 years.
Thefirst group included a consecutive series of 26 patients
(24 women, 2 men) that were treated from October 2000 to
June 2006 with the Delta III prosthesis (DePuy International,
Leeds, United Kingdom) (group D-3); mean age was 75 years
(range, 62–84).
The second group included a consecutive series of 31
patients (28 women, 3 men) that were treated from Febru-
ary 2011 to March 2015 with the Delta Xtend prosthesis
(DePuy International) (group D-XT); mean age was 72.5
years (range, 59–79). Two patients were treated bilaterally,
for a total of 33 implants.
Preoperative clinical data of the two groups of patients are
reported in ►Table 1.
All the surgical procedures were performed by the same
surgeon. The transdeltoid approach was used in 15 patients
of group D-3, while the deltopectoral approach was used in
all the remaining patients. In group D-XT, the subscapularis
tendon was never repaired at the end of the procedure.
The humeral component was cemented in 17 cases
(65.4%) of group D-3 and in 10 cases (30.3%) of group D-
XT. Retroversion of the humeral component varied among
patients of group D-3: 0 degrees in 6 cases, 5 degrees in 1,
Table 1 Demographical and clinical data of the two groups of
patients
Group D-3 Group D-XT
Period 2000–2006 2011–2015
Patients (n) 26 (24 ♀, 2 ♂) 31 (28 ♀, 3 ♂)
Implants (n) 26 33
Age (y) 75 (62–84) 72.5 (59–79)

























Abbreviations: AVN, avascular necrosis; CTA, cuff tear arthropathy.
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10 degrees in 16, and 20 degrees in 3 cases. In groupD-XT, the
humeral component was always implanted in 20degrees of
retroversion.
Rehabilitation protocol was influenced by the surgical
approach. Active elevation of the shoulder in the scapular
plane was immediately allowed after the deltopectoral ap-
proach, but it was delayed for 4 weeks after the transdeltoid
approach since the deltoid was partially detached from the
acromion. Assisted passive elevation was started in all
patients on the first postoperative day.
Clinical evaluationwith theConstant–Murleyscore (CMS)15
was performed preoperatively and at follow-up. The normal-
ized CMS scorewas expressed as a percentage of premeasured
normal values, matched for age and sex.16 Active ROM for
anterior elevation, external, and internal rotation was also
assessed.
After surgery, patients were recalled at intervals of 3, 6,
and 12 months and yearly thereafter for radiographic evalu-
ation in two orthogonal views (true anteroposterior and
axillary).
Scapular notching was assessed according to the Nerot
classification.17 The presence of radiolucent lines around the
humeral component, osteophytes, and heterotopic ossifica-
tions was also investigated. Radiolucent lines around the
humeral component were classified according to their width
( 2 or>2mm) and zones involved, as described by Sanchez-
Sotelo et al.18,19
Statistical analysis was performed to compare mean
variations in ROM and Constant scores from baseline to
follow-up between the two groups: p was obtained by
comparing follow-up data using baseline score as covariate
with an analysis of covariance model.
The difference in scapular notching incidence between
the two groups was compared using the Fisher’s exact test.
A p-value of<0.05 was considered statistically
significant.
Results
Twenty-three patients (88.4%) of group D-3were available at
an average follow-up of 42 months (range, 26–84); one
patient died of lung cancer and two patients could not be
evaluated due to debilitating neurological conditions unre-
lated to their surgery. Twenty-two patients, for a total of 24
implants (72.7%), of group D-XTwere evaluated at an average
follow-up 44 months (range, 26–66); three patients died
from causes unrelated to the surgical procedure, three were
unable to reach our institution for geographical distance, two
patients were hospitalized in geriatric structures for cogni-
tive impairment, and one patient was untraceable.
Two early postoperative complications were observed in
group D-3: one partial detachment of the lateral deltoid after
transdeltoid approach, that was treated conservatively and
healed uneventfully, and one dislocation, that was promptly
reduced and did not recur. An early deep infection occurred
in one patient of group D-XT 2 weeks after surgery: it was
treated with debridement, glenosphere, and humeral insert
replacement and 6-week targeted antibiotic therapy. At 4-
year follow-up, there were no clinical signs of infection and
laboratory tests (erythrocyte sedimentation rate, polymer-
ase chain reaction) were negative, but the patient com-
plained of recurrent shoulder discomfort and radiograms
showed progressive humeral radiolucency combined with
scapular notching (►Fig. 1).
Two cases of glenoid component loosening, respectively at
6 months and 5 years, occurred in group D-3: both patients
underwent revision surgery. In the first one, the glenoid
component was replaced using a special metaglene with a
plate for additional screw fixation and cancellous bone graft
tofill thebone defect at the scapular neck. The secondpatient
was treated with conversion to a hemiarthroplasty owing to
the extensive bone loss and low functional demands. No late
complications were observed in group D-XT.
Mean ROM and CMS of the two groups recorded preoper-
atively and at follow-up are shown in ►Table 2. The compar-
ison of ROM changes from baseline to follow-up between the
two groups did not show any significant difference
(►Table 3). Despite the greater improvement in rotations
observed in the D-XT group, significance was not reached
due to the differences in baseline values.
Average absolute CMS value increased by 32.4 points
(11.9) in the D-3 group and 38.3 points (10.0) in the
D-XT group. The between-group difference was statistically
significant (p¼0.007). Also for the normalized CMS, the
difference of 7.1 percentage points between the two groups
was significant (p¼0.012) (►Table 3).
The most relevant disparities between the two implants
were noticed in radiographic findings.
Incidence, severity, and trend to progression of the scap-
ular notch were higher in group D-3, as shown in ►Table 4.
Differences in incidence were found to be statistically signif-
icant every year during follow-up. Among patients whowere
Fig. 1 Humeral radiolucency observed in the patient who suffered an
early periprosthetic infection after implantation of a Delta Xtend
uncemented prosthesis. (A) Two years after surgery, humeral radio-
lucency is observed in zone 7 (black arrow). (B) At 4 years, radiolu-
cency progression is evident in zone 7 (black arrow) and there is initial
bone resorption also in zone 1 (white dotted arrow). Grade 1 notching
and an inferior heterotopic ossification are present at the scapular
neck.
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followed up for 5 years, the incidence of scapular notching
was 100% (10/10) for group D-3 and 22.2% (2/9) for group D-
XT. Moreover, Nerot grades 3 and 4 were only observed in 5
patients of group D-3 (►Fig. 2).
Humeral radiolucencies  2mm were observed in three
patients of group D-3 and in one of group D-XT. All the
components were uncemented and only metaphyseal zones
were involved (zones 1 and 7). In group D-3, radiolucencies
came into view 5 years after surgery and were always
associated with scapular notching (grade 2 or higher). In
group D-XT, there was only one case of progressive humeral
radiolucency combined with grade 1 scapular notching: this





Preop Follow-up Preop Follow-up
Forward elevation 66.1 (28.2) 132.6 ( 26.7) 63.1 (33.9) 140.6 (21.1)
External rotation 17.0 (13.4) 15.4 (10.5) 8.1 (19.1) 20.8 (11.8)
Internal rotation L3 L4 Sacrum L4
Absolute CMS 23.2 (9.8) 55.6 (9.2) 26.4 (7.8) 64.7 (10.7)
Pain 3.9 (3.0) 12.4 (3.0) 2.5 (2.9) 12.7 (3.6)
ADL 8.6 (3.5) 15.0 (2.9) 9.6 (2.9) 18.5 (2.2)
ROM 10.1 (5.2) 25.1 (5.5) 12.5 (6.2) 28.2 (6.8)
Strength 0.7 (0.9) 3.1 (1.4) 1.8 (2.3) 5.3 ( 2.9)
Normalized CMS 29.0% ( 12.3%) 69.6% ( 12.0%) 32.8% ( 9.6%) 80.5% (13.5%)
Abbreviations: ADL, activities of daily living; CMS, Constant–Murley score; ROM, range of motion.






Forward elevation þ66.5° ( 29þ .5°) þ77.5° ( 28.8°) 0.154
External rotation –1.6° (14.6°) þ12.7° ( 21.2°) 0.06
Internal rotation L3 ! L4 Sacrum ! L4 0.056
Absolute CMS þ32.4 ( 11.9) þ38.3 ( 10.0) 0.007a
Pain þ8.5 (4.1) þ10.2 ( 5.2) 0.897
ADL þ6.4 (3.5) þ8.9 ( 3.8) < 0.001a
ROM þ15.0 ( 6.8) þ15.7 ( 4.9) 0.295
Strength þ2.4 (1.4) þ3.5 ( 2.9) 0.014a
Normalized CMS þ40.5% ( 15.1%) þ48.9% (13.2%) 0.012a
Abbreviations: ADL, activities of daily living; CMS, Constant–Murley score; ROM, range of motion.
ap< 0.05.
Table 4 Comparison of incidence and severity of scapular notching during the study period between the two groups
Group D-3 Group D-XT
Nerot gradea Incidence n F/U n Incidence Nerot gradea p-Value
43.5% 23 1 year 24 8.5% 0.008
69.5% 23 2 years 24 12.5% < 0.001
88.9% 18 3 years 20 25% < 0.001
92.3% 13 4 years 13 23% 0.001
100% 10 5 years 9 22.2% 0.001
aShades of gray indicate different severity of the Nerot scale (light gray¼grade 1, dark gray¼grade 4).
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finding was observed in the patient with the early postoper-
ative infection (►Fig. 1).
Heterotopic ossifications in the axillary pouchwere found
in 4 patients of group D-3 and in 3 of group D-XT.
Discussion
Grammont prosthesis was the first model of RTSA extensive-
ly used by orthopaedic surgeons to treat cuff tear arthropa-
thy and other shoulder pathologies with rotator cuff
deficiency. Past experiences with the Delta 3 prosthesis
proved its clinical effectiveness, but at the same time
highlighted some drawbacks of this implant, the main one
being the high incidence of scapular notching.2,20–28 During
the last two decades, several design innovations and differ-
ent biomechanical solutions were adopted in newer RTSA to
overcome these problems.8–14 Greater acquaintance with
this surgery was also crucial to prevent mistakes in the
implant technique, another cause of the high rate of failures
and complications initially reported.22,23,26,27,29–33
In this study, we retrospectively reviewed the short-term
results achieved in two series of patients, who were treated
in two different time periods by a single experienced shoul-
der surgeon. In the earlier series, the first generation Delta
prosthesis (Delta 3) was used, while the second generation
Delta prosthesis (Delta Xtend) was implanted in the more
recent series of patients. Both implants rely on the original
Grammont’s biomechanical principles for RTSA, but some
improvement in design and instrumentation were adopted
in the Delta Xtend prosthesis, with the aim to improve
clinical and radiographic outcomes as well as to facilitate
the surgical procedure.24,27,34
Both prostheses showed to be very effective in recovering
active elevation in patients with pseudoparalytic shoulders,
but improvements in internal and external rotation were
more pronounced with the Delta Xtend. This observation
does not find a univocal explanation.
An improved external rotation might be related to the
different retroversion of the humeral component chosen in
the two series of patients. According to Grammont’s indica-
tion, most of the Delta 3 prostheseswere implanted between
0 and 10degrees of retroversion. Conversely, a 20-degree
retroversion angle was adopted for all the humeral compo-
nents of the Delta Xtend. This different orientation was
probably useful for gaining external rotation and did not
have any repercussion on internal rotation.
It has been reported that integrity of teres minor is a
critical factor for the recovery of external rotation after
RTSA,35 but we do not have sufficient data—namelymagnetic
resonance imaging findings—to assert that this factor influ-
enced the ROM differences between the two groups of
patients.
The role of the subscapularis in hindering external rota-
tion is still debated, but its repair in undue tension, particu-
larly with the deltopectoral approach and lateralized RTSA,
should be avoided. In our experience, the subscapularis was
never repaired in the patients treatedmore recently and this
choice might have contributed to improve recovery of exter-
nal rotation. At the same time, the absence of the subscapu-
laris did not impair either internal rotation or implant
stability, since no dislocation occurred in group D-XT.
Finally, the availability and the more extensive use of less
congruent humeral inserts14 and larger glenospheres are
implant-related factors that potentially played a role in
achieving wider ROMwith the second generation prosthesis.
The increase in CMS from baseline to follow-up was
significantly greater for the D-XT group, but the improve-
ments achieved in both groups are in accordance with the
data reported in the main clinical series found in litera-
ture.2,22,32,36–38 Our analysis showed that clinical results
might be improved by newer RTSA designs, even though
we could not demonstrate significant differences in ROM
changes in the comparison between the two groups. The
complication ratewas higher in the earlier series of patients:
18.2% versus 4.2%. This trend is mainly influenced by the
learning curve of RTSA and the refinement in surgical
technique and patient selection, as reported by other
authors.30–32 However, loosening of the glenoid component
occurred exclusively in two patients with the Delta 3 pros-
thesis. The absence of mechanical failures in group D-XT
leads us to suppose that inherent features of second genera-
tion implants also played a role in decreasing the complica-
tion rate.
Radiographic analysis showed a significant difference in
the incidence of scapular notching between the two series of
patients throughout the whole study period. A large amount
of research has been devoted to this topic, probably the most
debated in RTSA. In previous clinical studies, reported rates
Fig. 2 Comparison between scapular notching progression between
first and second generation implants. (A, B) Delta III: progression from
Nerot grade 2 at 1-year follow-up (A) to Nerot grade 4 at 4-year follow-
up (B). (C, D) Delta Xtend: progression from Nerot grade 1 at 1-year
follow-up (C) to Nerot grade 2 at 4-year follow-up (D).
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of scapular notching in the short-term ranged from 10 to
96%.2,20,22–27,35,39,40
Osteolysis at the scapular neck can derive either from
impingement of the medial border of the humeral implant
against the inferior rim of the glenoid or as a result of an
inflammatory response to polyethylene debris. The former
mechanism is thought to be responsible for low-grade notch-
ing and the latter for high-grade notching with severe bone
loss, eventually involving the proximal humerus.22,26,27,39
Several factors can influence ROM and impingement in
RTSA, contributing to onset and progression of scapular
notching. Patient-related factors include body mass index,
scapular neck angle, scapular neck length, and individual
biological reactivity to implant debris.11,23,26,27,41,42 Some
factors related to the surgical technique are critical: gleno-
sphere height and tilt above all, but also the version angles of
the components.11,23,24,26,27,34,40–43 Finally, implant design
features such as the position of the center of rotation,
glenosphere size and overhang, humeral neck angle, and
humeral insert constraint play a role.34,44,45 Efforts by sur-
geons andmanufacturing companies have been addressed to
improve surgical techniques and implant designs with the
aim to decrease the rate of scapular notching.23,24,34,40
The effect of scapular notching on clinical outcome is
controversial. Some authors reported a relationship between
scapular notching and poorer clinical results,22,27,35,46–48 but
others pointed out that severe scapular erosions might be
totally asymptomatic.2,25,26,28,39,49 In this study, we could
not find a correlation between notching and poorer clinical
outcomes in both series of patients.
An evenmore important issue is the potential progression
of scapular notching with time.20,26,27,39 Our experience
shows that the incidence of scapular notching with the first
generation prosthesis (100%) was five times higher than that
of the second generation implant (22.2%) at the 5-year
follow-up. Moreover, the severity of notching was also
greater in the earlier series of patients and caused loosening
of two glenoid components.
There are some limitations of this study that temper our
analysis and results interpretation, such as the retrospective
design and the short-term follow-up. Another important limi-
tation is the high drop-out rate (27.3%) observed at follow-up in
the D-XT group. The risk of losing patients at follow-up in RTSA
clinical studies is mainly related to the age: death or deteriora-
tion of general condition are common reasons of drop-out
among elderly patients. However, the clinical experience of a
single surgeonwith two different implants provides some food
for reflection on recent history of RTSA.
Grammont’s intuitions revolutionized the world of shoul-
der arthroplasty: despite the initial skepticism, his Delta
prosthesis conquered the market thanks to the outstanding
effectiveness in treating cuff-deficient shoulders. The early
clinical experience predictably highlighted the biomechani-
cal limits of the reverse configuration and their potential
consequences. Moreover, the incidence of major complica-
tions, such as infection, instability, or implant failure, was
generally high, even if appreciably influenced by preopera-
tive diagnosis.
For two decades, much research has been devoted to
develop new design solutions and refine implantation tech-
niques, to overcome drawbacks of the first generation pros-
thesis and improve clinical outcomes, particularly in the
medium and long term. In our experience, the short-term
results achieved with two different generations of Delta
prosthesis exhibited subtle clinical differences in terms of
shoulder functional recovery. Conversely, radiographic find-
ings of the second generation implant showed a clear de-
crease in scapular notching, whichmight be important in the
perspective of improving long-term results and survival
rates.
RTSA is still an evolving field of study. Alternative solu-
tions to the original biomechanical principles of Grammont
have been adopted in some reverse prostheses. Hopefully,
ongoing research and long-term clinical experiences will
show us which is the best way to go for further improving
outcomes and reliability of RTSA.
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